Laura Friel

MedRhythms, Inc.

MedRhythms is developing next-generation neurotherapeutics that leverage the power of music and technology to redefine what's possible in brain health, for patients around the world. Our devices are designed to improve walking, mobility and related functional outcomes via a proprietary, patented technology platform. This platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. We are developing a pipeline of digital therapeutics across a range of neurological conditions, including stroke, multiple sclerosis and Parkinson's disease. For more information about how we are pioneering digital therapeutics, visit https://medrhythms.com/